MRAM-Announcement
NIH: Availability of Supplements on COVID-19
Greetings Colleagues,
The National Heart, Lung, and Blood Institute (NHLBI) issued a notice to highlight the urgent need for research on COVID-19 and on the biological effects of SARS-CoV-2.
Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.
Guidance for NIH Funded Clinical Trials & Human Subjects Studies Affected by COVID-19
Greetings Colleagues,
NIH has issued guidance for clinical trials & human subjects studies impacted by COVID-19.
This notice reinforces the importance NIH places on the health and safety of human participants and research staff. It also provides guidance on how to handle Delays in Research Progress as well as Unanticipated Costs as a result of COVID-19.
NSF Extends Some March Deadlines
Greetings Colleagues,
NSF announced March deadline date extensions for some solicitations and Dear Colleague Letters (DCLs). Others may be added to the list and we strongly encourage you to check NSF’s Coronavirus website regularly.
Thank you,
Carol Rhodes
Director
Office of Sponsored Programs
Flexibilities for Applicants and Awardees due to COVID-19
Greetings Colleagues,
The Dept. of Energy (DOE) has issued a Special Announcement for Applicants and Awardees announcing flexibilities due to COVID-19. The announcement details guidance and Q&A for COVID-19 challenges faced by DOE applicants and awardees.
Topics covered include:
NIH Announces Flexibilities for Applicants and Recipients Affected by COVID-19
Greetings Colleagues,
NIH announced flexibilities for applicants and recipients affected by COVID-19 as well as accompanying FAQs.
These flexibilities are applicable to NIH applicants and recipients where the entity is conducting research activities related to or affected by COVID-19.
CORE Announces In-Person Class Cancellations and Plans to Zoom
Dear Colleagues,
As the University of Washington has been proactive with response to COVID-19, and the implementation of plans to move all instruction and exams out of the classroom, we in CORE feel the need to be similarly responsive. We will offer alternatives to our in-person classes until the situation with COVID-19 is resolved to the point where we can again safely resume these classes.
New NSF Coronavirus Information Website
Greetings Colleagues,
NSF has developed a collection of Coronavirus resources relevant to NSF funded research.
Some key takeaways:
NIH: COVID-19 FAQs and Late Submission Policy
Greetings Colleagues,
When delays occur because an applicant organization is officially closed or unable to submit grant applications due to the effects of COVID-19, the NIH will consider accepting late applications, on a case-by-case basis.
At this time, the University of Washington is not officially closed and we are able to submit applications. Review OSP's business continuity information.